Eos Advisory



Wobble Genomics hails £1.2m investment round led by Eos Advisory

RiboNucleic Acid (RNA) sequencing specialist Wobble Genomics has raised a £1.2 million investment round led by Eos Advisory.

Published 2 September 2021

Eos Advisory set for further growth in 2021 after record year of activity

St Andrews-based investment firm Eos Advisory is set for further growth in 2021 after a record year of activity in 2020.

Published 1 April 2021

ClinSpec Diagnostics Limited completes £3.5m funding round

Glasgow-based ClinSpec Diagnostics Limited (ClinSpec Dx) has reached its round two funding target of £3.5 million by securing an additional investment of £1.1m.

Published 4 March 2021

Eos Advisory enters partnership with US-based Kineticos

St Andrews-based investment firm Eos Advisory has entered into a strategic partnership with US-based Kineticos Life Sciences to co-invest in early stage Scottish life sciences companies.

Published 15 February 2021

Chris Brinsmead joins Eos Advisory as partner

Chris Brinsmead CBE, the former senior AstraZeneca executive and experienced non-executive director, has joined St Andrews-based investment firm Eos Advisory as a partner.

Published 25 January 2021

Greenshoots: Digital Sports Arena secures global publishing deal with Playstack

Dundee-based sports video game developer Digital Sports Arena has secured a global publishing deal with international games group Playstack for its latest game, GameDayLive.

Published 18 January 2021

RAB-Microfluidics secures £1.24m investment round led by Eos Advisory

RAB-Microfluidics, an Aberdeen R&D company developing cutting-edge microfluidic technology that solves oil analysis problems, has secured a £1.24 million investment round led by Eos Advisory.

Published 5 January 2021

Eos Advisory appoints Mark Beaumont to executive team

St Andrews-based investment firm Eos Advisory has appointed Mark Beaumont to its leadership team to help deliver its strategic growth plans over the coming years.

Published 26 November 2020

Eos Advisory backs Europe’s first oncology drug discovery accelerator Cumulus

St Andrews-based investment firm Eos Advisory has backed Europe’s first oncology drug discovery accelerator, Cumulus Oncology, leading a £1.7 million investment round.

Published 13 July 2020

GM Flow secures six-figure funding package from trio of investors

Aberdeen-based gas flow management company GM Flow has secured a six-figure investment package from the Scottish Investment Bank (SIB), the investment arm of Scottish Enterprise, Alba Equity and Eos Advisory.

Published 27 February 2020